华森制药(002907.SZ)：收到药品再注册批准通知书

Core Viewpoint - Huason Pharmaceutical (002907.SZ) has received approval from the Chongqing Municipal Drug Administration for the re-registration of one chemical raw material and one drug, indicating a positive regulatory development for the company [1] Group 1: Product Approvals - The company received a "Chemical Raw Material Re-registration Approval Notice" for the chemical raw material named Povidone Iodine, which is used in various formulations such as Povidone Iodine solution and Povidone Iodine ointment [1] - The company also obtained a "Drug Re-registration Approval Notice" for the drug named Injection Gabexate Mesilate, which is used for the treatment of acute mild (edematous) pancreatitis and can also assist in the treatment of acute hemorrhagic necrotizing pancreatitis [1]